Testimonial: Bola (Adetoun Soyombo)

Posted on 19 November 2018 by Ian

Bola (Adetoun Soyombo) - Periodontist“I found the course an excellent introduction to photobiomodulation therapy. James Carroll and his brilliant team presented the lectures and ran the hands on session in an excellent manner which saw everyone wanting more information. A fantastic training course.

The support following the course has been excellent and I am using my Thor laser machine more and more each day. I would highly recommend not just the course but investing in the lasers. You do get one of the most brilliant minds .. James helping you navigate the exciting world of pain and healing therapy without drugs.”

Bola (Adetoun Soyombo)
Periodontist
Buckinghamshire, UK

View current photobiomodulation therapy training dates in your location.

Posted in Testimonials | Leave a comment

NovoTHOR testimonial: Performance Bodywork

Posted on 18 November 2018 by Ian

Customers of Performance Bodywork in Portland, Oregon speak how NovoTHOR has improved and changed their lives.

View current photobiomodulation therapy training dates in your location.

More NovoTHOR Testimonials

Disclaimer: These comments by healthcare professionals and their patients are solely their own. They are uncompensated personal stories about how they have used, or been impacted by, light therapy. These uses have not been reviewed or cleared by FDA.

Posted in Testimonials, Video of the Week | Leave a comment

Shining a Light on PBM & The Health Care Innovation Ecosystem

Posted on 12 November 2018 by Ian

By Ms. Hannah M Clark, Global NetGeneration of Youth Cyberjournalist, with support from Dr. Ronnie Lowenstein, Executive Director Global NetGeneration of Youth

NGY Cyberjournalist Hannah Clark being inspired by the passion of Mr. James Carroll, founder and CEO of THOR Medicine.Recently, I was honored to be invited by Dr. Robert Boege, Executive Director of ASTRA to join ASTRA’s Futurist Dr. Ronnie Lowenstein, and serve as a NetGeneration of Youth Cyberjournalist covering a Congressional Briefing held in the Rayburn House Office Building on October 11, 2018 entitled, “Ending Opioid Use: A New Hope”.  The event was co-sponsored by ASTRA, The World Association for Laser Therapy, NetGeneration of Youth, The Optical Society of America, and thirteen other science and medical organizations.  What an opportunity to learn about PBM, “photobiomodulation,” an innovative medical technology, as well as, to be exposed to the organizational stakeholders who advocate for support of America’s ‘science and technology innovation ecosystem.’

What is PBM and What does it Promise?
When I first heard the term photobiomodulation (PBM) I was confused—initially the word sounded like a lighting technique for theater productions. Then as I started researching, it seemed more like a tool for physics experiments involving light. Only when I attended the Congressional Briefing and heard the first-hand testimony of people who miraculously benefited from using this medical technology did I begin to grasp its far-reaching implications for both revolutionizing health care and for serving as an alternative solution to the prescription opioid crisis.

Read the full news story on usinnovation.org

Posted in Industry, THE FUTURE OF LLLT | Leave a comment

LumiThera and Optos Announce Collaboration to Commercialize the Valeda™ Light Delivery System for Treating Dry Age-Related Macular Degeneration in Europe

Posted on 24 October 2018 by James Carroll

LumiThera's Valeda® Light Delivery SystemLumiThera Inc., a commercial-stage medical device company focused on developing photobiomodulation (PBM) therapies for ocular disorders and disease, announced a distribution agreement with Optos Plc, a division of Nikon, Inc., Japan to exclusively distribute the Valeda™ Light Delivery System for the treatment of dry age-related macular degeneration (AMD) in 12 European countries. Optos is recognized as the leading provider of ultra-widefield retinal imaging devices to eyecare professionals for improved patient eye care. The announcement follows the recent CE Mark Certification for the European Union (EU) for the treatment of dry AMD utilizing LumiThera’s Valeda™ Light Delivery System.

“The Distribution agreement with Optos allows LumiThera to begin commercialization throughout Europe and establishes a collaboration with a partner in the retinal imaging area,” stated Clark Tedford, Ph.D., LumiThera President and CEO. “Optos is a global leader in ultra-widefield retinal imaging technologies and we are honored to be working with them to open up a new age in the treatment of AMD.”

“Optos is pleased to add the Valeda™ Light Delivery System to our product range and to further support eye care professionals to diagnose and manage retinal diseases. This arrangement allows our customers to visualize AMD in the far periphery with color and autofluorescence ultra-widefield retinal imaging and provide a PBM treatment for dry AMD. This is very important for the patients who have this complicated, degenerative disease,” stated Robert Kennedy, Chief Executive Officer, Optos.

LumiThera recently sponsored a symposium on PBM in ocular disease and presented final data from the LIGHTSITE I study at the Euretina conference in September 2018 and has a multi-center trial in Europe planned to begin in the near term to further support clinical, anatomical, and patient benefits with the Valeda™ Light Delivery System. The therapy consists of a series of light-based treatments to the retinal cells, resulting in improved energy production and addressing inflammation, ischemia and metabolic dysfunction that contribute to the disease.

View the press release on Lumithera website at www.lumithera.com

Disclosure: I am an investor in Lumithera a) because it successfully treats an unmet medical need, (dry AMD) b) I think it will be the first billion dollar photobiomodulation company.

Posted in Industry | Leave a comment

PBM Therapy Literature Watch February 2018

Posted on 29 August 2018 by James Carroll

36 Photobiomodulation therapy papers published in February 2018. Highlights include:

  • DNA repair mechanisms, modulation of telomere maintenance
  • Improved motor response in patients with spinal cord injury
  • Prevention of < grade 2 radiodermatitis in breast cancer patients (RCT)
  • No adverse effects on SCC primary cancer, recurrence or survival
  • Improved physiological and performance parameters in runners
  • Improved depth of anaesthesia during endodontic treatment

Continue reading →

Posted in Research | Leave a comment

R. Hirschberg DVM | How THOR impacts clients and our relationships

Posted on 10 August 2018 by Ian

Ronald E. Hirschberg DVM talks about how using THOR’s equipment has strengthened his relationships with his clients and improved their pet’s health.

Read more about Veterinary Photobiomodulation Therapy

Disclaimer: These comments by healthcare professionals and their patients are solely their own. They are uncompensated personal stories about how they have used, or been impacted by, light therapy. These uses have not been reviewed or cleared by FDA.

Posted in Interviews, Testimonials, Veterinary, Video of the Week | Leave a comment

NovoTHOR testimonial: Meagan.W – Dallas, TX, USA

Posted on 27 April 2016 by Ian

National Level WeightlifterMeagan is a National Level Weightlifter who competes frequently. See her story and experience below after sessions on the NovoTHOR whole-body light pod. PR stands for Personal Record.

Wednesday 3/16:
Muscle Snatch Triple off a riser: PR working weight at 42 kg… Up 5 kilos from last week where I could only hit 37kg for working weight.

Thursday 3/17:
My 3/6 front squat/back squat combo I added 3 kilos from the previous Thursday- which is the most working I’ve ever done for this exercise at 91kg.

THEN I went on to do several reps of cleans and hit a 95kg Clean PR (9 kilos more than I did last week- heaviest clean I hit last week was 86kg.) This was halfway through my workout after doing a total of 117 reps. In Weightlifting a lot of volume can make your body feel tired & wrecked, so there was no explanation for why I was able to hit a PR on this exercise when my legs were fried.

Saturday 3/19: I hit a 3 kilo PR on my Power Clean & Jerk at 83kg

Sunday 3/20:
I added 2 kilos to my snatch triples from the blocks (59kg) from last week where I could only do 57kg.

I also did the most working weight I’ve ever done for Clean & Jerk Doubles at 83kg.

Monday 3/21:
Sumo Deadlift triple: 127kg PR (up 5 kilos from last Monday 3/14 I only could hit 122kg for 3)

Snatch Deadlift 5 rep: PR working weight for 5 at 91kg (2 kilos more than last Monday.)

Push Press+Push Jerk + Split Jerk Complex: 75kg (up 2kg from last Monday’s workout)

This part of my training cycle has been very strength intensive, so for me to even be coming close to hitting PRs is a huge deal. My body should be more fatigued and worn down from the strength work, but I actually feel recovered and fresh.

This is all thanks to the NovoTHOR light pod.

More NovoTHOR Testimonials

Posted in Testimonials | Leave a comment

Pubmed to adopt “Photobiomodulation Therapy” as a MeSH term

Posted on 25 January 2015 by James Carroll

The US National Library of Medicine (NLM) plans to adopt “Photobiomodulation Therapy” (PBMT) as an official MeSH term in November 2015.

Why this is important?

Continue reading →

Posted in THE FUTURE OF LLLT | Leave a comment

THOR LLLT presentation at United Nations – Global Health Impact Forum

Posted on 10 June 2014 by James Carroll

This 15 minute video starts with an overview of Photobiomodulation and low level light therapy. Later in the presentation James introduces the Lumithera treatment for Dry Age related Macular Degeneration (AMD).

Posted in THE FUTURE OF LLLT | 5 Comments

More Class IV laser therapy misinformation

Posted on 10 June 2014 by James Carroll

More Class IV laser therapy misinformationThe paper “High-intensity versus low-level laser therapy in the treatment of patients with knee osteoarthritis: a randomized controlled trial” Kheshie et al 2014 pitches the 3B BTL laser against the HIRO class IV “High intensity” laser. The results appear to show that the HIRO class IV “High intensity laser” was more effective than the “Low Level Laser”. HOWEVER, the HIRO class IV “High intensity” laser was delivered over a large area (not adequately defined but approx 100cm2 by my estimation) so the intensity was actually very low (about 13mW/cm2 which is less than most LED systems), and the 3B BTL “Low Level Laser” was actually very high (4 x 200mW small, high intensity beams) and were held stationary on the patella for over half an hour, YES, HALF AN HOUR IN ONE SPOT! This is insane.

This paper leads people to think that the class IV Hiro laser was more effective because it was higher intensity when in fact the beam distribution meant the average intensity distribution was low (13mW/cm2). The 3B laser was not so effective because it was held stationary such that it would cause an overdose. If the 3B laser treatment had been delivered in using same scanning technique as the class IV then they would likely have achieved the same result. (I am not a fan of scanning because you can never be sure how much energy you have delivered to an area, better to use a low intensity device and hold it still in my view).

This paper misdirects the reader towards favouring class IV lasers rather than 3b or LED by misinforming the reader.

Continue reading →

Posted in Rants | 1 Comment

Class IV laser dose concern. An update from Prof. Jan Bjordal. World Association for Laser Therapy (WALT)

Posted on 30 November 2013 by James Carroll

The title of last months PMLS editorial was Low Level Laser Therapy (LLLT) and World Association for Laser Therapy (WALT) Dosage Recommendations. Written by the Scientific Secretary Prof. Jan Bjordal. He describes how far we have come and the importance of the WALT dosage recommendations. No abstract is available for editorials so I have prepared one for you below. Continue reading →

Posted in Rants, Special Feature | Leave a comment

Class IV laser treatments take longer than 3B lasers

Posted on 20 November 2013 by James Carroll

A paper titled ”The Effectiveness of Therapeutic Class IV (10 W) Laser Treatment for Epicondylitis” [ref] showed that 10 Watt Class IV laser (mixed 8W 970nm, 2W 810) was successful in reducing pain and improving function in an RCT with 15 patients, and that there was good statistical significance at 6 months following a course of 6 treatments.

The claim by class IV laser manufacturers is that class IV lasers are better (faster, deeper and more effective) than Class 3b and LED systems. Conversely the 3B laser and LED manufacturers argue that less power density is more effective because delivering energy too quickly can overdose tissues and class IV lasers might burn the skin.

Throughout this paper there are marketing messages claiming the advantages  of shorter treatment times than low power LLLT systems and of course the title shouts “10 Watt Class IV laser” just in case the reader is in any doubt that more power is what you need.

Regular readers of this column know my obsession with irradiation parameters, particularly dose rate effects (W/cm2) and will not be surprised to learn that I deconstruced the irradiation parameters used in this trial . Surprise, surprise they were the same low irradiance levels typically used by 3B lasers and LED systems, if not less and the treatment time was longer too.

Yes, it was a 10 Watt laser and yes, 3,000 joules was delivered, however it had a  large beam area and treatment was delivered over (45cm2) in a “painting fashion”. The fluence (dose) was 6.6 Joules/cm2 and the power density was a tiny 22mW/cm2, consequently  treatment time was a hefty 5 mins.

The average irradiance was not disclosed in the paper and the reader is directed to think that more power is quicker.

P.S.  research trials with 3B lasers are typically 30 seconds to 3 mins and our recommended treatment is 1 min with a large LED cluster to the lateral epicondyle and 30 seconds for any related trigger points.

Posted in Rants, Research | Leave a comment

The THOR LLLT Treatment Library

Posted on 24 February 2012 by James Carroll

Available only to THOR Customers and/or people who have attended a THOR training course in the last 3 years. All treatments are based on our four step method which includes treatment of the injury, trigger points, lymphatics and nerve roots.

Take a look to see how it works and let us know what you think.

Access Treatment Protocol Library

Posted in Special Feature | 3 Comments

THOR laser in UK National Health Service (NHS) clinical trial for treatment of Oral Mucositis

Posted on 15 November 2018 by Ian

Laser therapy to ease cancer treatment side effects | ITV News

MPH LiTFORM ITV news release Sept 2018

Read more on Photobiomodulation Therapy for reducing severity and duration of oral mucositis.

Posted in Industry, THE FUTURE OF LLLT | Leave a comment

NovoTHOR testimonial: Texas Laser Therapy – Trino Pedraza

Posted on 7 November 2018 by Ian

Trino Pedraza talks about results for his chronic back and neck pain at Texas Laser Therapy.

View current photobiomodulation therapy training dates in your location.

More NovoTHOR Testimonials

Disclaimer: These comments by healthcare professionals and their patients are solely their own. They are uncompensated personal stories about how they have used, or been impacted by, light therapy. These uses have not been reviewed or cleared by FDA.

Posted in Testimonials, Video of the Week | Leave a comment

NovoTHOR testimonial: Texas Laser Therapy – Garrett Poole

Posted on 5 November 2018 by Ian

Garrett Poole, Black Belt martial artist and owner of Extreme Martial Arts in New Braunfels came to Texas Laser Therapy looking for help with 3 nagging injuries that wouldn’t heal. He has healed and now is seeing impressive Sports Performance & Recovery benefits from daily use of the NovoTHOR Whole Body Light Pod at Texas Laser Therapy in New Braunfels, TX.

View current photobiomodulation therapy training dates in your location.

More NovoTHOR Testimonials

Disclaimer: These comments by healthcare professionals and their patients are solely their own. They are uncompensated personal stories about how they have used, or been impacted by, light therapy. These uses have not been reviewed or cleared by FDA.

Posted in Testimonials, Video of the Week | Leave a comment

New Technologies, Treatments Can End Opioid Use

Posted on 30 October 2018 by James Carroll

Those suffering from America’s opioid crisis recently received two major messages of hope.

On Oct. 24, President Donald Trump signed the Opioid Crisis Response Act (OCRA) into law. Dozens of bills designed to address the diverse aspects of the opioid crisis were consolidated into one strategic and integrated approach.

OCRA received overwhelming bi-partisan support in both Chambers.

HR6, which is now Public Law 115-2716, broke new ground in being the first legislation to mandate aggressive development and adoption of alternative pain treatments that include “innovative medical technologies for pain management.”

On Oct. 11, Congress held its first ever briefing on ending opioid use through “innovative medical technologies for pain management.”

Photobiomodulation (PBM) was the featured technology.

Read the full news story on newsmax.com

Posted in Industry, THE FUTURE OF LLLT | Leave a comment